# The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives

> **NCT02028026** · PHASE4 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Major Depressive Disorder
- Anxiety
- Comorbidity

## Interventions

- **DRUG:** Vilazodone
- **DRUG:** Citalopram

## Key facts

- **NCT ID:** NCT02028026
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-04
- **Primary completion:** 2015-02
- **Final completion:** 2015-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Inability to recruit eligible subjects
- **Last updated:** 2016-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02028026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02028026, "The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02028026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*